Evidence map›Paper›PMID 26998275›Full record

ArticleBiomedical reports2016

Association of the osteopontin rs1126616 polymorphism and a higher serum osteopontin level with lupus nephritis.

Saeedeh Salimi, Mehrangiz Noora, Sima Nabizadeh, Mahnaz Rezaei, Hossain Shahraki, Mohammadoo-Khorassani Milad, Anoosh Naghavi, Farzaneh Farajian-Mashhadi, Zahra Zakeri, Mahnaz Sandoughi

Open access · bronzeAbstract read
In one paragraph

Article in Biomedical reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Association of the rs1126616 and rs9138 Variants in theInternational journal of molecular sciences · 2024
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. The role of osteopontin in kidney diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2019
    Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Saeedeh SalimiCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran; Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran.
Mehrangiz NooraDepartment of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran.
Sima NabizadehDepartment of English Language, School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran.
Mahnaz RezaeiDepartment of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran.
Hossain ShahrakiCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran.
Mohammadoo-Khorassani MiladCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran; Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran.
Anoosh NaghaviCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran.
Farzaneh Farajian-MashhadiCellular and Molecular Research Center, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran; Department of Pharmacology, School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran.
Zahra ZakeriDepartment of Internal Medicine, School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran.
Mahnaz SandoughiDepartment of Internal Medicine, School of Medicine, Zahedan University of Medical Sciences, Zahedan 9816743175, Iran.
Zahedan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteopontin (OPN) is a chemokine-like glycoprotein that has a prominent role in regulating inflammation and immunity.

Indexed as

genelupus nephritisosteopontinpolymorphismsystemic lupus erythematosus

Identifiers

PMID26998275
PMCPMC4774351
OpenAlexW2272242647

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.